$3.47
0.247.43%
At close: Dec 16, 4:00 PM EST
$3.47
N/A
After Hours: 4:20 PM EST
Comments
Loading...
Hyperliquid Strategies (PURR) Stock Price, Quote, News & History
PURRNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Hyperliquid Strategies (PURR) stock?
You can purchase shares of Hyperliquid Strategies (NASDAQ:PURR) through any online brokerage.
Who are Hyperliquid Strategies (PURR) competitors?
Other companies in Hyperliquid Strategies’s space includes: Tectonic Therapeutic Inc (NASDAQ:TECX), Galectin Therapeutics Inc (NASDAQ:GALT), Larimar Therapeutics Inc (NASDAQ:LRMR), Immuneering Corp (NASDAQ:IMRX) and PepGen Inc (NASDAQ:PEPG).
What is the forecast, or price target, for Hyperliquid Strategies (PURR) stock?
Hyperliquid Strategies has a consensus price target of $5.00.
What is the current price for Hyperliquid Strategies (PURR)?
The stock price for Hyperliquid Strategies (NASDAQ: PURR) is $3.47 last updated December 16, 2025 at 4:20 PM EST.
Does Hyperliquid Strategies (PURR) pay a dividend?
There are no upcoming dividends for Hyperliquid Strategies.
When is Hyperliquid Strategies (NASDAQ:PURR) reporting earnings?
Hyperliquid Strategies does not have any upcoming earnings scheduled.
Is Hyperliquid Strategies (PURR) going to split?
There is no upcoming split for Hyperliquid Strategies.
What sector and industry does Hyperliquid Strategies (PURR) operate in?
Hyperliquid Strategies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
